⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for pathologic stage iii cutaneous melanoma ajcc v8

Every month we try and update this database with for pathologic stage iii cutaneous melanoma ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsNCT05039801
Advanced Endome...
Advanced Head a...
Advanced Malign...
Advanced Melano...
Advanced Ovaria...
Chondrosarcoma
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Recurrent Ovari...
Refractory Endo...
Refractory Head...
Refractory Mela...
Refractory Ovar...
Refractory Ovar...
Stage III Ovari...
Stage III Uteri...
Stage IIIA Ovar...
Stage IIIA Uter...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Ovar...
Stage IIIB Uter...
Stage IIIC Ovar...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Ovaria...
Stage IV Uterin...
Stage IVA Ovari...
Stage IVA Uteri...
Stage IVB Ovari...
Stage IVB Uteri...
Bevacizumab
Glutaminase-1 I...
Paclitaxel
Capivasertib
18 Years - M.D. Anderson Cancer Center
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesNCT02419495
Advanced Malign...
Clinical Stage ...
Clinical Stage ...
Fallopian Tube ...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Metastatic Rena...
Ovarian Carcino...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Primary Periton...
Stage III Lung ...
Stage III Renal...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Lung ...
Stage IVB Lung ...
Triple-Negative...
Unresectable Lu...
Unresectable Me...
Unresectable Re...
Capecitabine
Carboplatin
Cyclophosphamid...
Doxorubicin
Eribulin
Fluorouracil
Ipilimumab
Irinotecan Hydr...
Leucovorin Calc...
Nivolumab
Olaparib
Oxaliplatin
Paclitaxel
Pembrolizumab
Pemetrexed
Selinexor
Topotecan
18 Years - M.D. Anderson Cancer Center
Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV MelanomaNCT03865212
Clinical Stage ...
Clinical Stage ...
Metastatic Chor...
Metastatic Mela...
Metastatic Muco...
Metastatic Uvea...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Unresectable Me...
Recombinant Ves...
18 Years - Mayo Clinic
Study of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable MelanomaNCT04995094
Pathologic Stag...
Imprime PGG
Pembrolizumab
18 Years - HiberCell, Inc.
Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint InhibitorsNCT04990726
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Melanoma, Stage...
Melanoma Stage ...
Assessment
Biospecimen Col...
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center
Bone Loss in Melanoma Survivors Receiving ImmunotherapyNCT04516122
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Biospecimen Col...
Dual X-ray Abso...
40 Years - M.D. Anderson Cancer Center
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaNCT04940299
Clinical Stage ...
Clinical Stage ...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Malignant Solid...
Metastatic Blad...
Metastatic Blad...
Metastatic Lung...
Metastatic Mela...
Metastatic Rena...
Metastatic Uret...
Metastatic Uret...
Metastatic Uret...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage III Bladd...
Stage III Lung ...
Stage III Renal...
Stage III Urete...
Stage III Ureth...
Stage IIIA Blad...
Stage IIIA Lung...
Stage IIIB Blad...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Bladde...
Stage IV Lung C...
Stage IV Renal ...
Stage IV Ureter...
Stage IV Urethr...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Me...
Ipilimumab
Nivolumab
Tocilizumab
18 Years - M.D. Anderson Cancer Center
Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype MelanomaNCT04375527
Clinical Stage ...
Clinical Stage ...
Locally Advance...
Metastatic Cuta...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Unresectable Cu...
Binimetinib
Nivolumab
Questionnaire A...
18 Years - Jonsson Comprehensive Cancer Center
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsNCT05039801
Advanced Endome...
Advanced Head a...
Advanced Malign...
Advanced Melano...
Advanced Ovaria...
Chondrosarcoma
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Recurrent Ovari...
Refractory Endo...
Refractory Head...
Refractory Mela...
Refractory Ovar...
Refractory Ovar...
Stage III Ovari...
Stage III Uteri...
Stage IIIA Ovar...
Stage IIIA Uter...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Ovar...
Stage IIIB Uter...
Stage IIIC Ovar...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Ovaria...
Stage IV Uterin...
Stage IVA Ovari...
Stage IVA Uteri...
Stage IVB Ovari...
Stage IVB Uteri...
Bevacizumab
Glutaminase-1 I...
Paclitaxel
Capivasertib
18 Years - M.D. Anderson Cancer Center
Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III MelanomaNCT03554083
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Atezolizumab
Cobimetinib
Tiragolumab
Vemurafenib
18 Years - Mayo Clinic
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerNCT03819296
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Colitis
Lung Non-Small ...
Malignant Genit...
Malignant Solid...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage 0 Lung Ca...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Best Practice
Biospecimen Col...
Endoscopic Proc...
Fecal Microbiot...
Infliximab
Laboratory Biom...
Prednisone
Vedolizumab
18 Years - M.D. Anderson Cancer Center
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesNCT04902040
Advanced Bladde...
Advanced Lung N...
Advanced Malign...
Advanced Melano...
Advanced Merkel...
Advanced Renal ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage III Bladd...
Stage III Lung ...
Stage III Renal...
Stage IIIA Blad...
Stage IIIA Lung...
Stage IIIB Blad...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Bladde...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Bladd...
Stage IVA Lung ...
Stage IVB Bladd...
Stage IVB Lung ...
Atezolizumab
Avelumab
Durvalumab
Nivolumab
Pembrolizumab
Plinabulin
Radiation Thera...
18 Years - M.D. Anderson Cancer Center
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesNCT04902040
Advanced Bladde...
Advanced Lung N...
Advanced Malign...
Advanced Melano...
Advanced Merkel...
Advanced Renal ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage III Bladd...
Stage III Lung ...
Stage III Renal...
Stage IIIA Blad...
Stage IIIA Lung...
Stage IIIB Blad...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Bladde...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Bladd...
Stage IVA Lung ...
Stage IVB Bladd...
Stage IVB Lung ...
Atezolizumab
Avelumab
Durvalumab
Nivolumab
Pembrolizumab
Plinabulin
Radiation Thera...
18 Years - M.D. Anderson Cancer Center
Effect of Diet on the Immune System in Patients With Stage III-IV Melanoma Receiving Immunotherapy, DIET StudyNCT04645680
Clinical Stage ...
Clinical Stage ...
Metastatic Mela...
Pathologic Stag...
Pathologic Stag...
Unresectable Me...
Dietary Interve...
Dietary Interve...
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center
Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV CancerNCT04067960
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Biliary Tract C...
Clinical Stage ...
Clinical Stage ...
Malignant Brain...
Malignant Genit...
Malignant Solid...
Pancreatobiliar...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage III Color...
Stage III Ovari...
Stage III Pancr...
Stage III Prost...
Stage IIIA Colo...
Stage IIIA Ovar...
Stage IIIA Pros...
Stage IIIB Colo...
Stage IIIB Ovar...
Stage IIIB Pros...
Stage IIIC Colo...
Stage IIIC Ovar...
Stage IIIC Pros...
Stage IV Colore...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IVA Color...
Stage IVA Ovari...
Stage IVA Pancr...
Stage IVA Prost...
Stage IVB Color...
Stage IVB Ovari...
Stage IVB Pancr...
Stage IVB Prost...
Stage IVC Color...
Biospecimen Col...
Genetic Testing
Quality-of-Life...
Questionnaire A...
- Mayo Clinic
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerNCT03819296
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Colitis
Lung Non-Small ...
Malignant Genit...
Malignant Solid...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage 0 Lung Ca...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Best Practice
Biospecimen Col...
Endoscopic Proc...
Fecal Microbiot...
Infliximab
Laboratory Biom...
Prednisone
Vedolizumab
18 Years - M.D. Anderson Cancer Center
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic CancersNCT03816332
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Metastatic Basa...
Metastatic Mela...
Metastatic Merk...
Metastatic Skin...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Unresectable Ba...
Unresectable Me...
Unresectable Me...
Ipilimumab
Nivolumab
Prednisone
Tacrolimus
18 Years - National Cancer Institute (NCI)
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsNCT05039801
Advanced Endome...
Advanced Head a...
Advanced Malign...
Advanced Melano...
Advanced Ovaria...
Chondrosarcoma
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Recurrent Ovari...
Refractory Endo...
Refractory Head...
Refractory Mela...
Refractory Ovar...
Refractory Ovar...
Stage III Ovari...
Stage III Uteri...
Stage IIIA Ovar...
Stage IIIA Uter...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Ovar...
Stage IIIB Uter...
Stage IIIC Ovar...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Ovaria...
Stage IV Uterin...
Stage IVA Ovari...
Stage IVA Uteri...
Stage IVB Ovari...
Stage IVB Uteri...
Bevacizumab
Glutaminase-1 I...
Paclitaxel
Capivasertib
18 Years - M.D. Anderson Cancer Center
Bone Loss in Melanoma Survivors Receiving ImmunotherapyNCT04516122
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Biospecimen Col...
Dual X-ray Abso...
40 Years - M.D. Anderson Cancer Center
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their FamiliesNCT03677739
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
First Degree Re...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Informational I...
Informational I...
Survey Administ...
18 Years - 80 YearsRutgers, The State University of New Jersey
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesNCT02419495
Advanced Malign...
Clinical Stage ...
Clinical Stage ...
Fallopian Tube ...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Metastatic Rena...
Ovarian Carcino...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Primary Periton...
Stage III Lung ...
Stage III Renal...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Lung ...
Stage IVB Lung ...
Triple-Negative...
Unresectable Lu...
Unresectable Me...
Unresectable Re...
Capecitabine
Carboplatin
Cyclophosphamid...
Doxorubicin
Eribulin
Fluorouracil
Ipilimumab
Irinotecan Hydr...
Leucovorin Calc...
Nivolumab
Olaparib
Oxaliplatin
Paclitaxel
Pembrolizumab
Pemetrexed
Selinexor
Topotecan
18 Years - M.D. Anderson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: